Anupama Goel, MD

Clinical Focus

• Breast Cancer

• Breast Cancer

Locations

Mount Sinai Doctors West 59th Street

425 West 59th Street, 9th Floor, New York, NY, 10019

212-523-5559

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Healthfirst Medicare Advantage insurance: Effective 9/1/2024, Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression. Alaina J. Kessler, Rima Patel, Emily Jane Gallagher, Tianxiang Sheng, Damodara Rao Mendu, Amy Tiersten, Paula Klein, Aarti S. Bhardwaj, Anupama Goel, Joseph A. Sparano, Theresa Shao, Julie Fasano. Breast Cancer Research and Treatment
• Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer. Matthew Kearney, Lauren Franks, Shing Lee, Amy Tiersten, Della F. Makower, Tessa Cigler, Prabhjot Mundi, Dow Chung Chi, Anupama Goel, Pam Klein, Eleni Andreopoulou, Joseph Sparano, Meghna Trivedi, Melissa Accordino, Andrea Califano, Dawn L. Hershman, Jose Silva, Kevin Kalinsky. Breast Cancer Research and Treatment
• Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York cancer consortium trial. Kerin Adelson, Bhuvaneswari Ramaswamy, Joseph A. Sparano, Paul J. Christos, John J. Wright, George Raptis, Gang Han, Miguel Villalona-Calero, Cynthia X. Ma, Dawn Hershman, Joseph Baar, Paula Klein, Tessa Cigler, G. Thomas Budd, Yelena Novik, Antoinette R. Tan, Susan Tannenbaum, Anupama Goel, Ellis Levine, Charles L. Shapiro, Eleni Andreopoulou, Michael Naughton, Kevin Kalinsky, Sam Waxman, Doris Germain. npj Breast Cancer

Industry Relationships